Farmacologia

Milnacipran in Fibromyalgia

In 2009, in the USA, the use of milnacipram (a selective serotonin-norepinephrine reuptake inhibitor) was approved for the treatment of fibromyalgia. With a trial sponsored by pharmaceutical industry, 1025 patients affected by this disease for an average period of 11 years have been treated with milnacipram or placebo.
Approfondisci

 http://mn.medsurfnews.com/contents/en/6273/display/milnacipr...

MedNews